• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观察性血清保护研究中流行动力学引起的潜在偏倚。

Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies.

出版信息

Am J Epidemiol. 2021 Feb 1;190(2):328-335. doi: 10.1093/aje/kwaa188.

DOI:10.1093/aje/kwaa188
PMID:32870977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7499481/
Abstract

The extent and duration of immunity following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical outstanding questions about the epidemiology of this novel virus, and studies are needed to evaluate the effects of serostatus on reinfection. Understanding the potential sources of bias and methods for alleviating biases in these studies is important for informing their design and analysis. Confounding by individual-level risk factors in observational studies like these is relatively well appreciated. Here, we show how geographic structure and the underlying, natural dynamics of epidemics can also induce noncausal associations. We take the approach of simulating serological studies in the context of an uncontrolled or controlled epidemic, under different assumptions about whether prior infection does or does not protect an individual against subsequent infection, and using various designs and analytical approaches to analyze the simulated data. We find that in studies assessing whether seropositivity confers protection against future infection, comparing seropositive persons with seronegative persons with similar time-dependent patterns of exposure to infection by stratifying or matching on geographic location and time of enrollment is essential in order to prevent bias.

摘要

感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)后免疫的范围和持续时间是关于这种新型病毒流行病学的关键未解决问题,需要研究来评估血清阳性状态对再感染的影响。了解这些研究中潜在偏差的来源和减轻偏差的方法对于为其设计和分析提供信息很重要。在这种观察性研究中,个体水平风险因素的混杂相对容易理解。在这里,我们展示了地理结构和潜在的流行病自然动态如何也会引起非因果关系。我们采用在不受控制或受控制的流行情况下模拟血清学研究的方法,根据先前的感染是否确实或是否不能保护个体免受随后的感染做出不同的假设,并使用各种设计和分析方法来分析模拟数据。我们发现,在评估血清阳性是否对未来感染提供保护的研究中,通过在地理区域和入组时间上分层或匹配来比较具有相似感染暴露时间依赖性模式的血清阳性者和血清阴性者,对于防止偏差至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/7849971/c924b7bace59/kwaa188f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/7849971/e61d78e841df/kwaa188f1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/7849971/cbef79d98866/kwaa188f1e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/7849971/c924b7bace59/kwaa188f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/7849971/e61d78e841df/kwaa188f1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/7849971/cbef79d98866/kwaa188f1e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/7849971/c924b7bace59/kwaa188f2.jpg

相似文献

1
Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies.观察性血清保护研究中流行动力学引起的潜在偏倚。
Am J Epidemiol. 2021 Feb 1;190(2):328-335. doi: 10.1093/aje/kwaa188.
2
Potential biases arising from epidemic dynamics in observational seroprotection studies.观察性血清学保护研究中流行动力学产生的潜在偏倚。
medRxiv. 2020 May 6:2020.05.02.20088765. doi: 10.1101/2020.05.02.20088765.
3
Analyzing inherent biases in SARS-CoV-2 PCR and serological epidemiologic metrics.分析 SARS-CoV-2 PCR 和血清流行病学指标中的固有偏倚。
BMC Infect Dis. 2022 May 13;22(1):458. doi: 10.1186/s12879-022-07425-z.
4
How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19.如何发现和减少 SARS-CoV-2 和 COVID-19 研究中的潜在偏倚源。
Eur J Epidemiol. 2021 Feb;36(2):179-196. doi: 10.1007/s10654-021-00727-7. Epub 2021 Feb 25.
5
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.旅行相关的控制措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717.
6
SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.在一项多中心血清流行病学工作场所队列研究中,SARS-CoV-2 抗体至少能预防 6 个月的再次感染。
PLoS Biol. 2022 Feb 10;20(2):e3001531. doi: 10.1371/journal.pbio.3001531. eCollection 2022 Feb.
7
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.2020 年 4 月伊朗吉兰省 SARS-CoV-2 的血清流行率。
Emerg Infect Dis. 2021 Feb;27(2):636-638. doi: 10.3201/eid2702.201960. Epub 2020 Dec 21.
8
Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark.丹麦大型医护人员队列中 SARS-CoV-2 感染后血清阴性的危险因素。
Microbiol Spectr. 2021 Oct 31;9(2):e0090421. doi: 10.1128/Spectrum.00904-21. Epub 2021 Oct 20.
9
Association of infection-induced antibody levels with risk of subsequent SARS-COV-2 reinfection among healthcare professionals, Rhode Island, 1 March 2020-17 February 2021.2020年3月1日至2021年2月17日罗德岛医护人员中感染诱导抗体水平与后续新冠病毒再次感染风险的关联
Microbiol Spectr. 2025 Apr;13(4):e0208624. doi: 10.1128/spectrum.02086-24. Epub 2025 Feb 25.
10
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.严重、中度和轻度 COVID-19 病例恢复期样本中 SARS-CoV-2 感染的血清学生物标志物分析。
Front Immunol. 2021 Nov 19;12:748291. doi: 10.3389/fimmu.2021.748291. eCollection 2021.

引用本文的文献

1
Design of field trials for the evaluation of transmissible vaccines in animal populations.用于评估动物群体中可传播疫苗的现场试验设计。
PLoS Comput Biol. 2025 Feb 3;21(2):e1012779. doi: 10.1371/journal.pcbi.1012779. eCollection 2025 Feb.
2
ADDRESSING SELECTION BIAS AND MEASUREMENT ERROR IN COVID-19 CASE COUNT DATA USING AUXILIARY INFORMATION.利用辅助信息解决新冠疫情病例数数据中的选择偏倚和测量误差问题。
Ann Appl Stat. 2023 Dec;17(4):2903-2923. doi: 10.1214/23-aoas1744. Epub 2023 Oct 30.
3
Comparative Evaluation of Rapid Isothermal Amplification and Antigen Assays for Screening Testing of SARS-CoV-2.

本文引用的文献

1
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.SARS-CoV-2 血清学检测:关注、机遇与未来方向。
Sci Immunol. 2020 May 19;5(47). doi: 10.1126/sciimmunol.abc6347.
2
News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.新闻特写:避免在研发新冠疫苗过程中陷入困境。
Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8218-8221. doi: 10.1073/pnas.2005456117. Epub 2020 Mar 30.
3
Depletion-of-susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness.分析流感疫苗效果在季节内衰减时的易感者偏倚。
快速等温扩增与抗原检测用于 SARS-CoV-2 筛查试验的比较评估。
Viruses. 2022 Feb 25;14(3):468. doi: 10.3390/v14030468.
4
Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics.模拟种族和民族差异对新冠疫情动态的影响。
Elife. 2021 May 18;10:e66601. doi: 10.7554/eLife.66601.
5
Cabbage and COVID-19.卷心菜与新型冠状病毒肺炎
Allergy. 2021 Mar;76(3):966-967. doi: 10.1111/all.14654.
6
How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19.如何发现和减少 SARS-CoV-2 和 COVID-19 研究中的潜在偏倚源。
Eur J Epidemiol. 2021 Feb;36(2):179-196. doi: 10.1007/s10654-021-00727-7. Epub 2021 Feb 25.
Clin Infect Dis. 2020 Mar 17;70(7):1484-1486. doi: 10.1093/cid/ciz706.
4
Competing Effects of Indirect Protection and Clustering on the Power of Cluster-Randomized Controlled Vaccine Trials.间接保护和聚集效应对群组随机对照疫苗试验效力的竞争影响。
Am J Epidemiol. 2018 Aug 1;187(8):1763-1771. doi: 10.1093/aje/kwy047.
5
Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials.风险率中随机产生的异质性对个体随机疫苗疗效试验的影响。
Clin Trials. 2018 Apr;15(2):207-211. doi: 10.1177/1740774517752671. Epub 2018 Jan 27.
6
Simulations for designing and interpreting intervention trials in infectious diseases.用于设计和解释传染病干预试验的模拟
BMC Med. 2017 Dec 29;15(1):223. doi: 10.1186/s12916-017-0985-3.
7
Temporally Varying Relative Risks for Infectious Diseases: Implications for Infectious Disease Control.传染病的时变相对风险:对传染病控制的影响
Epidemiology. 2017 Jan;28(1):136-144. doi: 10.1097/EDE.0000000000000571.
8
Use of serological surveys to generate key insights into the changing global landscape of infectious disease.利用血清学调查对不断变化的全球传染病格局产生关键见解。
Lancet. 2016 Aug 13;388(10045):728-30. doi: 10.1016/S0140-6736(16)30164-7. Epub 2016 Apr 5.
9
Network theory and SARS: predicting outbreak diversity.网络理论与非典:预测疫情多样性。
J Theor Biol. 2005 Jan 7;232(1):71-81. doi: 10.1016/j.jtbi.2004.07.026.
10
The ecological effects of individual exposures and nonlinear disease dynamics in populations.个体暴露的生态效应及人群中的非线性疾病动态
Am J Public Health. 1994 May;84(5):836-42. doi: 10.2105/ajph.84.5.836.